Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 834

1.

Long-term outcomes of nonconditioned patients with severe combined immunodeficiency transplanted with HLA-identical or haploidentical bone marrow depleted of T cells with anti-CD6 mAb.

Patel NC, Chinen J, Rosenblatt HM, Hanson IC, Brown BS, Paul ME, Abramson SL, Ritz J, Shearer WT.

J Allergy Clin Immunol. 2008 Dec;122(6):1185-93. doi: 10.1016/j.jaci.2008.10.030.

PMID:
19084111
2.

CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.

Soiffer RJ, Mauch P, Fairclough D, Alyea E, Anderson K, Fisher D, Freedman A, Bartlett-Pandite L, Robertson M, Schlossman R, Gollob J, Marcus K, Murray C, Kuhlman C, Freeman A, Nadler L, Ritz J.

Biol Blood Marrow Transplant. 1997 Apr;3(1):11-7.

PMID:
9209736
3.

HLA non-identical T-cell-depleted bone marrow transplantation for primary immunodeficiency diseases.

Giri N, Vowels M, Ziegler JB, Ford D, Lam-Po-Tang R.

Aust N Z J Med. 1994 Feb;24(1):26-30.

PMID:
8002854
4.

Bone marrow transplantation from genetically HLA-nonidentical donors in children with fatal inherited disorders excluding severe combined immunodeficiencies: use of two monoclonal antibodies to prevent graft rejection.

Jabado N, Le Deist F, Cant A, De Graeff-Meeders ER, Fasth A, Morgan G, Vellodi A, Hale G, Bujan W, Thomas C, Cavazzana-Calvo M, Wijdenes J, Fischer A.

Pediatrics. 1996 Sep;98(3 Pt 1):420-8.

PMID:
8784367
5.

T cell depleted haploidentical bone marrow transplantation for the treatment of children with severe combined immunodeficiency.

Smogorzewska EM, Brooks J, Annett G, Kapoor N, Crooks GM, Kohn DB, Parkman R, Weinberg KI.

Arch Immunol Ther Exp (Warsz). 2000;48(2):111-8.

PMID:
10807052
6.

Long-term immune reconstitution and outcome after HLA-nonidentical T-cell-depleted bone marrow transplantation for severe combined immunodeficiency: a European retrospective study of 116 patients.

Haddad E, Landais P, Friedrich W, Gerritsen B, Cavazzana-Calvo M, Morgan G, Bertrand Y, Fasth A, Porta F, Cant A, Espanol T, Müller S, Veys P, Vossen J, Fischer A.

Blood. 1998 May 15;91(10):3646-53.

7.

Influence of severe combined immunodeficiency phenotype on the outcome of HLA non-identical, T-cell-depleted bone marrow transplantation: a retrospective European survey from the European group for bone marrow transplantation and the european society for immunodeficiency.

Bertrand Y, Landais P, Friedrich W, Gerritsen B, Morgan G, Fasth A, Cavazzana-Calvo M, Porta F, Cant A, Espanol T, Müller S, Veys P, Vossen J, Haddad E, Fischer A.

J Pediatr. 1999 Jun;134(6):740-8.

PMID:
10356144
8.

Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency.

Buckley RH, Schiff SE, Schiff RI, Markert L, Williams LW, Roberts JL, Myers LA, Ward FE.

N Engl J Med. 1999 Feb 18;340(7):508-16.

9.

Kinetics of T-cell development of umbilical cord blood transplantation in severe T-cell immunodeficiency disorders.

Knutsen AP, Wall DA.

J Allergy Clin Immunol. 1999 May;103(5 Pt 1):823-32.

PMID:
10329816
11.
12.

XomaZyme-CD5 immunotoxin in conjunction with partial T cell depletion for prevention of graft rejection and graft-versus-host disease after bone marrow transplantation from matched unrelated donors.

Koehler M, Hurwitz CA, Krance RA, Coustan-Smith E, Williams LL, Santana V, Ribeiro RC, Brenner MK, Heslop HE.

Bone Marrow Transplant. 1994 May;13(5):571-5.

PMID:
7519937
13.

Prevention of graft-versus-host disease in DLA-haplotype mismatched dogs and hemopoietic engraftment of CD6-depleted marrow with and without cG-CSF treatment after transplantation.

Schumm M, Günther W, Kolb HJ, Rieber P, Büttner M, Voss C, Kremmer E, Reitmeier P, Thierfelder S, Wilmanns W.

Tissue Antigens. 1994 Mar;43(3):170-8.

PMID:
7522357
14.
15.

Comparable outcome with T-cell-depleted unrelated-donor versus related-donor allogeneic bone marrow transplantation.

Alyea EP, Weller E, Fisher DC, Freedman AS, Gribben JG, Lee S, Schlossman RL, Stone RM, Friedberg J, DeAngelo D, Liney D, Windawi S, Ng A, Mauch P, Antin JH, Soiffer RJ.

Biol Blood Marrow Transplant. 2002;8(11):601-7.

PMID:
12463479
16.

In vitro T cell depletion using Campath 1M for mismatched BMT for severe combined immunodeficiency (SCID).

Dickinson AM, Reid MM, Abinun M, Peak J, Brigham K, Dunn J, Cant AJ.

Bone Marrow Transplant. 1997 Feb;19(4):323-9.

18.

Treatment of Omenn syndrome by bone marrow transplantation.

Gomez L, Le Deist F, Blanche S, Cavazzana-Calvo M, Griscelli C, Fischer A.

J Pediatr. 1995 Jul;127(1):76-81.

PMID:
7608815
19.

T-cell-depleted allogeneic bone marrow transplantation for acute leukaemia using Campath-1 antibodies and post-transplant administration of donor's peripheral blood lymphocytes for prevention of relapse.

Naparstek E, Or R, Nagler A, Cividalli G, Engelhard D, Aker M, Gimon Z, Manny N, Sacks T, Tochner Z, et al.

Br J Haematol. 1995 Mar;89(3):506-15.

PMID:
7734348
20.

Outcome of unrelated donor bone marrow transplantation in 40 children with Hurler syndrome.

Peters C, Balthazor M, Shapiro EG, King RJ, Kollman C, Hegland JD, Henslee-Downey J, Trigg ME, Cowan MJ, Sanders J, Bunin N, Weinstein H, Lenarsky C, Falk P, Harris R, Bowen T, Williams TE, Grayson GH, Warkentin P, Sender L, Cool VA, Crittenden M, Packman S, Kaplan P, Lockman LA, Anderson J, Krivit W, Dusenbery K, Wagner J.

Blood. 1996 Jun 1;87(11):4894-902.

Supplemental Content

Support Center